|
|
Genentech chairman resigns from Google board
WASHINGTON (AFP) - Genentech chairman Arthur Levinson has resigned from the board of directors of Google amid a probe by US authorities into his membership of the boards of both the Internet giant and Apple.
People:Eric Schmidt Steve Jobs Source:(AFP)
2009-10-13
In colon cancer drug study, more wasn't better
NEW YORK - Doctors thought that combining two newer drugs that more precisely attack cancer would help people with advanced colon cancer. Instead, it made the cancer worse and made the patients more miserable, a study found. The surprising findings underscore the importance of doing rigorous studies before rushing to mix these pricey, new-generation drugs, the Dutch researchers and other experts said.
Nations:Netherlands Source:(AP)
2009-02-04
Eli Lilly agrees to buy ImClone for over $6B
NEW YORK - The drugmaker Eli Lilly & Co. said Monday it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand its pipeline of cancer treatments.
Nations:U.S. People:Carl Icahn Source:(AP)
2008-10-06
Study: Extending time of stroke drug treatment OK
LOS ANGELES - Stroke sufferers can still benefit from clot-busting medicine even if they receive it an hour or so beyond the current three-hour window after symptoms start, an important new study suggests.
Nations:U.S. Source:(AP)
2008-09-24
Roche seen likely to raise bid for Genentech
LOS ANGELES (Reuters) - Roche Holding AG (ROG.VX) may need to raise its $43.7 billion bid for the Genentech Inc (DNA.N) stock that it does not already own, but an eventual deal is likely, analysts and investors said on Monday.
Nations:U.S. Japan
2008-07-21
| Headlines |
|
Matches Shown: | 1-50 | 51-100
|
|
|
